Statistics about coronavirus and COVID-19
Here is a selection of key data and statistics about SARS-CoV-2 and COVID-19 disease in Norway.
Article
Published Updated
News
Showing 1352 hits
-
-
Statistics
On this page you will find selected statistics about coronavirus vaccination.
Article
Published Updated
-
Weekly reports for coronavirus and COVID-19
Here you will find the weekly report about coronavirus and COVID-19-epidemic in Norway. The latest summary is translated to English, earlier versions of the reports can be found below.
Report
Published Updated
-
Influenza vaccine for pregnant women
Pregnant women are at increased risk of a severe influenza disease course. Pregnant women in their 2nd and 3rd trimesters should take the influenza vaccine. Women in the 1st trimester with other additional risk factors are also recommended to take the vaccine.
Article
Published Updated
-
Vaccine recommendations for influenza season 2022-2023
Almost 1.6 million people in Norway belong to groups with an increased risk of complications from influenza. They are recommended to take the seasonal influenza vaccine.
Article
Published Updated
-
Influenza vaccine for risk groups
Anyone can become seriously ill from influenza, but certain risk groups are more susceptible to a severe disease course than others. The health benefits can be considerable if people in these risk groups are vaccinated.
Article
Published Updated
-
Influenza vaccine for children
Most children and young adolescents can tolerate influenza (the ‘flu), but some can become seriously ill. Children and young people in risk groups often have a severe disease course and are therefore recommended to receive the influenza vaccine.
Article
Published
-
Coronavirus vaccine
The purpose of vaccination against COVID-19 is to prevent disease or to give a milder disease course without being exposed to serious side effects.
Article
Published Updated
-
About NorEPIS
NorEPIS (Norwegian Enhanced Paediatric Immunisation Surveillance Network) is a research network for diseases that can be prevented by vaccination.
Article
Published Updated
-
Development and approval of coronavirus vaccine
Several biotechnology companies, global vaccine manufacturers and other organisations are developing vaccines against COVID-19 disease.
Article
Published Updated
-
Who will get the coronavirus vaccine?
Here you will find information about which groups are offered coronavirus vaccine and when we expect that the various groups will have received an offer.
Article
Published Updated
-
Emergency preparedness register for COVID-19 (Beredt C19)
The register (Beredt C19) was established to give the NIPH an ongoing overview and knowledge of the prevalence, causal relationships and consequences of the COVID-19 epidemic in Norway.
Article
Published Updated
-
Remote patient monitoring and resource use in the specialized health service revised edition
We conducted an overview of six systematic reviews that studied the effects of remote patient monitoring of adults with noncommunicable diseases on resource use in the specialized health service.
Systematic review
Published
-
Access to genetic data after quality control by the MoBaPsychGen pipeline v.1
The PsychGen project has performed a comprehensive quality control of the genetic data in MoBa. This work is ongoing, led by Elizabeth Corfield and a collaboration between the Norwegian Institute of Public Health and NORMENT. The first version of quality-controlled data
Article
Published Updated
-
Global partners
Norway has been in the forefront of the global health arena, and the Global Health Preparedness Programme (GHPP) has served as an implementation tool for global health security.
Article
Published Updated
-
The Global Health Security Agenda
The Global Health Security Agenda (GHSA) is an active and diverse group of partners focusing on overseas health threats.
Article
Published Updated
-
The International Health Regulations 2005 (IHR)
The International Health Regulations (IHR 2005) are a legally binding instrument aiming to improve countries’ ability to protect and respond to international spread of disease, including epidemics.
Article
Published Updated
-
NORM og NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway
This report, which is the twenty-first annual joint report from NORM and NORM-VET, presents data on resistance and usage for 2021.
Report
Published
-
Intravenous ketamine for treatment-resistant depression and suicidal ideation
In this single technology assessment, we form a basis for a future health technology assessment, by mapping research on the effects of intravenous ketamine for treatment-resistant depression and acute suicide risk/-ideation.
Health technology assessment
Published
-
If you have been exposed to monkeypox infection (close contact)
This article contains advice if you who have been in contact with a person who has monkeypox.
Article
Published Updated